NCT02248688View on ClinicalTrials.gov

Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Arterial EmbolizationOther Surgical ProceduresObesity
Interventions
DEVICE

BeadBlock 300 - 500 Micron

Beadblock will be used intraarterially to occlude the left gastric artery and its branches. The left gastric artery supplies the fundus of the stomach, where it is known that the hormone Ghrelin (one of the hormones responsible for appetite) is produced.

PROCEDURE

Left Gastric Artery Embolization

Trial Locations (1)

45409

Dayton Interventional Radiology, Dayton

All Listed Sponsors
collaborator

Ohio State University

OTHER

lead

Dayton Interventional Radiology

OTHER

NCT02248688 - Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically | Biotech Hunter | Biotech Hunter